Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikas Madan

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Haematologica|October 15, 2020
Differentiation therapy of myeloid leukemia: four decades of developmentVikas Madan, H Phillip Koeffler
Oncotarget|December 22, 2014
Short-hairpin RNA library: identification of therapeutic partners for gefitinib-resistant non-small cell lung cancerMakoto Sudo, Seiichi Mori, Vikas Madan, et al.
Nature Methods|March 10, 2009
Hematopoietic stem cell transplantation without irradiationClaudia Waskow, Vikas Madan, Susanne Bartels, et al.
Molecular and Cellular Biology|April 1, 2009
The pluripotency-associated gene Dppa4 is dispensable for embryonic stem cell identity and germ cell development but essential for embryogenesisBabita Madan, Vikas Madan, Odile Weber, et al.
Scientific Reports|October 9, 2019
Identification of somatic alterations in lipoma using whole exome sequencingDeepika Kanojia, Pushkar Dakle, Anand Mayakonda, et al.
Immunity|March 23, 2010
Fate mapping reveals separate origins of T cells and myeloid lineages in the thymusSusan M Schlenner, Vikas Madan, Katrin Busch, et al.
The Journal of Experimental Medicine|July 11, 2012
Thymus-autonomous T cell development in the absence of progenitor importVera C Martins, Eliana Ruggiero, Susan M Schlenner, et al.
International Journal of Molecular Sciences|June 26, 2026
Correction: Shyamsunder et al. THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 1207Pavithra Shyamsunder, Shree Pooja Sridharan, Vikas Madan, et al.
International Journal of Molecular Sciences|February 15, 2022
THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair InhibitorsPavithra Shyamsunder, Shree Pooja Sridharan, Vikas Madan, et al.
Haematologica|May 19, 2018
<i>CARD10</i>, a CEBPE target involved in granulocytic differentiationPavithra Shyamsunder, Haresh Sankar, Anand Mayakonda, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Haematologica|October 15, 2020
Differentiation therapy of myeloid leukemia: four decades of developmentVikas Madan, H Phillip Koeffler
Oncotarget|December 22, 2014
Short-hairpin RNA library: identification of therapeutic partners for gefitinib-resistant non-small cell lung cancerMakoto Sudo, Seiichi Mori, Vikas Madan, et al.
Nature Methods|March 10, 2009
Hematopoietic stem cell transplantation without irradiationClaudia Waskow, Vikas Madan, Susanne Bartels, et al.
Molecular and Cellular Biology|April 1, 2009
The pluripotency-associated gene Dppa4 is dispensable for embryonic stem cell identity and germ cell development but essential for embryogenesisBabita Madan, Vikas Madan, Odile Weber, et al.
Scientific Reports|October 9, 2019
Identification of somatic alterations in lipoma using whole exome sequencingDeepika Kanojia, Pushkar Dakle, Anand Mayakonda, et al.
Immunity|March 23, 2010
Fate mapping reveals separate origins of T cells and myeloid lineages in the thymusSusan M Schlenner, Vikas Madan, Katrin Busch, et al.
The Journal of Experimental Medicine|July 11, 2012
Thymus-autonomous T cell development in the absence of progenitor importVera C Martins, Eliana Ruggiero, Susan M Schlenner, et al.
International Journal of Molecular Sciences|June 26, 2026
Correction: Shyamsunder et al. THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 1207Pavithra Shyamsunder, Shree Pooja Sridharan, Vikas Madan, et al.
International Journal of Molecular Sciences|February 15, 2022
THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair InhibitorsPavithra Shyamsunder, Shree Pooja Sridharan, Vikas Madan, et al.
Haematologica|May 19, 2018
<i>CARD10</i>, a CEBPE target involved in granulocytic differentiationPavithra Shyamsunder, Haresh Sankar, Anand Mayakonda, et al.
Pageof 4